Tamoxifen - Revision history

Michael at 18:26, 30 August 2023

2023-08-30T18:26:22Z

← Older revision		Revision as of 18:26, 30 August 2023
Line 5:		Line 5:
	==See also==		==See also==
	*[[Clinical]].		*[[Clinical]].
			*[[Endometrium with changes due to selective progesterone receptor modulators]].

	==References==		==References==

Michael at 18:25, 30 August 2023

2023-08-30T18:25:48Z

← Older revision		Revision as of 18:25, 30 August 2023
Line 1:		Line 1:
	'''Tamoxifen''' is a drug that an anti-estrogen effect. It is used to treat [[breast cancer]].		'''Tamoxifen''' is a drug that an anti-estrogen effect. It is used to treat [[breast cancer]].

	The classic teaching is that it increases the risk of [[endometrial cancer]]; however, the risk is quite small<ref name=pmid19505894>{{Cite journal \| last1 = Brown \| first1 = K. \| title = Is tamoxifen a genotoxic carcinogen in women? \| journal = Mutagenesis \| volume = 24 \| issue = 5 \| pages = 391-404 \| month = Sep \| year = 2009 \| doi = 10.1093/mutage/gep022 \| PMID = 19505894 }}</ref> ~~or possibly negligent.~~<ref name=pmid19827879>{{Cite journal \| last1 = Ashraf \| first1 = M. \| last2 = Biswas \| first2 = J. \| last3 = Majumdar \| first3 = S. \| last4 = Nayak \| first4 = S. \| last5 = Alam \| first5 = N. \| last6 = Mukherjee \| first6 = KK. \| last7 = Gupta \| first7 = S. \| title = Tamoxifen use in Indian women--adverse effects revisited. \| journal = Asian Pac J Cancer Prev \| volume = 10 \| issue = 4 \| pages = 609-12 \| month = \| year = \| doi = \| PMID = 19827879 }}</ref> Use is also associated with [[endometrial polyp]]s.		The classic teaching is that it increases the risk of [[endometrial cancer]]; however, the risk is quite small or possibly negligent.<ref name=pmid19505894>{{Cite journal \| last1 = Brown \| first1 = K. \| title = Is tamoxifen a genotoxic carcinogen in women? \| journal = Mutagenesis \| volume = 24 \| issue = 5 \| pages = 391-404 \| month = Sep \| year = 2009 \| doi = 10.1093/mutage/gep022 \| PMID = 19505894 }}</ref><ref name=pmid19827879>{{Cite journal \| last1 = Ashraf \| first1 = M. \| last2 = Biswas \| first2 = J. \| last3 = Majumdar \| first3 = S. \| last4 = Nayak \| first4 = S. \| last5 = Alam \| first5 = N. \| last6 = Mukherjee \| first6 = KK. \| last7 = Gupta \| first7 = S. \| title = Tamoxifen use in Indian women--adverse effects revisited. \| journal = Asian Pac J Cancer Prev \| volume = 10 \| issue = 4 \| pages = 609-12 \| month = \| year = \| doi = \| PMID = 19827879 }}</ref> Use is also associated with [[endometrial polyp]]s.

	==See also==		==See also==

Michael at 18:25, 30 August 2023

2023-08-30T18:25:27Z

← Older revision		Revision as of 18:25, 30 August 2023
Line 1:		Line 1:
	'''Tamoxifen''' is a drug that an anti-estrogen effect. It is used to treat [[breast cancer]].		'''Tamoxifen''' is a drug that an anti-estrogen effect. It is used to treat [[breast cancer]].

	The classic teaching is that it increases the risk of [[endometrial cancer]]; however, the risk is quite small<ref name=pmid19505894>{{Cite journal \| last1 = Brown \| first1 = K. \| title = Is tamoxifen a genotoxic carcinogen in women? \| journal = Mutagenesis \| volume = 24 \| issue = 5 \| pages = 391-404 \| month = Sep \| year = 2009 \| doi = 10.1093/mutage/gep022 \| PMID = 19505894 }}</ref> or possibly negligent.<ref name=pmid19827879>{{Cite journal \| last1 = Ashraf \| first1 = M. \| last2 = Biswas \| first2 = J. \| last3 = Majumdar \| first3 = S. \| last4 = Nayak \| first4 = S. \| last5 = Alam \| first5 = N. \| last6 = Mukherjee \| first6 = KK. \| last7 = Gupta \| first7 = S. \| title = Tamoxifen use in Indian women--adverse effects revisited. \| journal = Asian Pac J Cancer Prev \| volume = 10 \| issue = 4 \| pages = 609-12 \| month = \| year = \| doi = \| PMID = 19827879 }}</ref>		The classic teaching is that it increases the risk of [[endometrial cancer]]; however, the risk is quite small<ref name=pmid19505894>{{Cite journal \| last1 = Brown \| first1 = K. \| title = Is tamoxifen a genotoxic carcinogen in women? \| journal = Mutagenesis \| volume = 24 \| issue = 5 \| pages = 391-404 \| month = Sep \| year = 2009 \| doi = 10.1093/mutage/gep022 \| PMID = 19505894 }}</ref> or possibly negligent.<ref name=pmid19827879>{{Cite journal \| last1 = Ashraf \| first1 = M. \| last2 = Biswas \| first2 = J. \| last3 = Majumdar \| first3 = S. \| last4 = Nayak \| first4 = S. \| last5 = Alam \| first5 = N. \| last6 = Mukherjee \| first6 = KK. \| last7 = Gupta \| first7 = S. \| title = Tamoxifen use in Indian women--adverse effects revisited. \| journal = Asian Pac J Cancer Prev \| volume = 10 \| issue = 4 \| pages = 609-12 \| month = \| year = \| doi = \| PMID = 19827879 }}</ref> Use is also associated with [[endometrial polyp]]s.

	==See also==		==See also==
Line 11:		Line 11:
	[[Category:Breast pathology]]		[[Category:Breast pathology]]
	[[Category:Clinical]]		[[Category:Clinical]]
			[[Category:Drugs]]

Michael: Created page with "'''Tamoxifen''' is a drug that an anti-estrogen effect. It is used to treat breast cancer. The classic teaching is that it increases the risk of endometrial cancer; h..."

2023-08-30T18:23:46Z

Created page with "'''Tamoxifen''' is a drug that an anti-estrogen effect. It is used to treat breast cancer. The classic teaching is that it increases the risk of endometrial cancer; h..."

New page

'''Tamoxifen''' is a drug that an anti-estrogen effect. It is used to treat [[breast cancer]].

The classic teaching is that it increases the risk of [[endometrial cancer]]; however, the risk is quite small<ref name=pmid19505894>{{Cite journal | last1 = Brown | first1 = K. | title = Is tamoxifen a genotoxic carcinogen in women? | journal = Mutagenesis | volume = 24 | issue = 5 | pages = 391-404 | month = Sep | year = 2009 | doi = 10.1093/mutage/gep022 | PMID = 19505894 }}</ref> or possibly negligent.<ref name=pmid19827879>{{Cite journal | last1 = Ashraf | first1 = M. | last2 = Biswas | first2 = J. | last3 = Majumdar | first3 = S. | last4 = Nayak | first4 = S. | last5 = Alam | first5 = N. | last6 = Mukherjee | first6 = KK. | last7 = Gupta | first7 = S. | title = Tamoxifen use in Indian women--adverse effects revisited. | journal = Asian Pac J Cancer Prev | volume = 10 | issue = 4 | pages = 609-12 | month = | year = | doi = | PMID = 19827879 }}</ref>

==See also==
*[[Clinical]].

==References==
{{Reflist|1}}

[[Category:Breast pathology]]
[[Category:Clinical]]